ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,221.42
-0.02%
US Tech 100
17,716.80
0.19%
다우존스 지수
39,431.51
-0.21%
Bitcoin
62,907.63
0.01%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. InMed Pharmaceuticals Inc (INM)

  7. InMed Pharmaceuticals Inc (INM) 뉴스

INM

InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INM
일자시간출처헤드라인심볼기업
2024/03/0605:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2024/03/0605:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2024/03/0605:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2024/02/2805:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2024/02/2303:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2024/02/2204:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2024/02/1407:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMInMed Pharmaceuticals Inc
2024/02/1002:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
2024/01/2004:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
2024/01/1704:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2703:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/12/2207:21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:INMInMed Pharmaceuticals Inc
2023/12/0623:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
2023/11/3004:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
2023/11/1414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMInMed Pharmaceuticals Inc
2023/11/1407:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INMInMed Pharmaceuticals Inc
2023/11/0907:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INMInMed Pharmaceuticals Inc
2023/11/0303:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
2023/10/2805:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INMInMed Pharmaceuticals Inc
2023/10/2805:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMInMed Pharmaceuticals Inc
2023/10/2505:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
2023/09/3006:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:INM

최근 히스토리

AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
FX
USDJPY
US Dollar vs Yen
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
NYSE
AXP
American Express
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
NYSE
BAC
Bank of America
NYSE
NKE
Nike
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유